Iohexol contrast medium induces QT prolongation in amiodarone patients

    loading  Checking for direct PDF access through Ovid



Amiodarone is widely used in ventricular tachyarrhythmias and atrial fibrillation, known to prolong QT-intervals. Concurrent administration of drugs prolonging QT-time can induce life-threatening ventricular tachyarrhythmia.


QT-interval changes following use of Iohexol contrast-medium for coronarangiography were observed comparing 21 patients taking long-term amiodarone therapy with 21 controls not taking amiodarone or QT-prolonging drugs retrospectively.


Concurrent use of Iohexol and amiodarone was associated with significant prolongation of QTc-interval (433, 95%CI: 419–448 ms vs. 480, 95%CI: 422–483 ms, P < 0.001) the day after coronarangiograpgy. 6/21 patients showed severe prolonged QTc-interval of >500 ms.


Caution is advised until more is known about pro-arrhythmic effects of Iohexol.

Related Topics

    loading  Loading Related Articles